Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

TELA Bio, Inc. - Common stock (NQ:TELA)

1.870 -0.050 (-2.60%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 159,126
Open 1.920
Bid (Size) 1.860 (4)
Ask (Size) 1.910 (2)
Prev. Close 1.920
Today's Range 1.860 - 2.050
52wk Range 0.8645 - 5.800
Shares Outstanding 39,388,443
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire

Performance

YTD
-35.1%
-35.1%
1 Month
+85.1%
+85.1%
3 Month
-18.7%
-18.7%
6 Month
-37.0%
-37.0%
1 Year
-66.4%
-66.4%

More News

Read More
TELA Bio Announces European Commercial Launch of OviTex® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair
From TELA Bio, Inc.
Via GlobeNewswire
Earnings Scheduled For May 8, 2025
Via Benzinga
TELA Bio Appoints Jeffrey Blizard as President
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference
From TELA Bio, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio Reports First Quarter 2025 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio to Announce First Quarter 2025 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
TELA Bio Announces U.S. Commercial Launch of Larger Sizes of OviTex® PRS for Plastic and Reconstructive Surgery
From TELA Bio, Inc.
Via GlobeNewswire
Top stock movements in today's session.
Via Chartmill
Here are the top movers in Friday's session.
Via Chartmill
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Which stocks are gapping on Friday?
Via Chartmill
Gold Down Over 1%; Micron Technology Shares Fall After Q2 Earnings
Via Benzinga
Discover the top movers in Friday's pre-market session.
Via Chartmill
Dow Tumbles Over 400 Points; Nike Shares Dip After Q3 Results
Via Benzinga
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Get insights into the top gainers and losers of Thursday's after-hours session.
Via Chartmill
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
TELA Bio Reports Fourth Quarter and Full Year 2024 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire
Earnings Scheduled For March 20, 2025
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
TELA Bio to Announce Fourth Quarter and Full Year 2024 Financial Results
From TELA Bio, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is TELA Bio, Inc. - Common stock publicly traded?
Yes, TELA Bio, Inc. - Common stock is publicly traded.
What exchange does TELA Bio, Inc. - Common stock trade on?
TELA Bio, Inc. - Common stock trades on the Nasdaq Stock Market
What is the ticker symbol for TELA Bio, Inc. - Common stock?
The ticker symbol for TELA Bio, Inc. - Common stock is TELA on the Nasdaq Stock Market
What is the current price of TELA Bio, Inc. - Common stock?
The current price of TELA Bio, Inc. - Common stock is 1.870
When was TELA Bio, Inc. - Common stock last traded?
The last trade of TELA Bio, Inc. - Common stock was at 06/11/25 04:00 PM ET
What is the market capitalization of TELA Bio, Inc. - Common stock?
The market capitalization of TELA Bio, Inc. - Common stock is 73.66M
How many shares of TELA Bio, Inc. - Common stock are outstanding?
TELA Bio, Inc. - Common stock has 74M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.